Clinical trial
Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis
NCT07317804 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- April 26, 2026
- Completion date
- July 31, 2028
- Enrollment
- 212 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis, tavi, tavi(transcatheter aortic valve implantation)